Qualcomm vs Roche: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Qualcomm and Roche side by side

1. 1896Roche

   F. Hoffmann-La Roche Founded in Basel

   Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.

2. 1898Roche

   Commercial Breakthrough with Sirolin

   Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.

3. 1934Roche

   First Industrial Synthesis of Vitamin C

   Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.

4. 1963Roche

   Launch of Valium (Diazepam)

   Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.

5. 1968Roche

   Establishment of Roche Diagnostics

   Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.

6. 1985Qualcomm

   Qualcomm Founded

   Irwin Jacobs, Andrew Viterbi, and five colleagues found Qualcomm Incorporated in San Diego, California, initially operating as a telecommunications consulting and research firm from a converted restaurant building.

7. 1988Qualcomm

   OmniTRACS Commercial Launch

   Qualcomm commercially launches OmniTRACS, a satellite-based two-way messaging and positioning system for long-haul trucking that becomes the company's first profitable product and funds ongoing CDMA research.

8. 1989Qualcomm

   First Live CDMA Demonstration

   Qualcomm conducts its first outdoor live CDMA demonstration in San Diego, proving the technology works in real-world conditions and attracting serious attention from U.S. Cellular carriers and equipment manufacturers.

9. 1991Qualcomm

   Initial Public Offering

   Qualcomm goes public on the Nasdaq Stock Market in December 1991, raising approximately $43 million at $16 per share in an IPO that gives the company capital to accelerate CDMA commercialization.

10. 1993Qualcomm

    IS-95 CDMA Standard Adopted

    The Telecommunications Industry Association formally adopts IS-95, a CDMA standard based substantially on Qualcomm's technology, as an approved digital cellular standard in the United States validating the company's decade-long technological bet.

11. 1995Qualcomm

    First Commercial CDMA Network Launched

    Sprint PCS launches the first commercial CDMA cellular network in the United States, using Qualcomm-based technology and marking the beginning of large-scale commercial deployment that would define U.S. Wireless infrastructure for the next twenty years.

12. 1999Qualcomm

    Strategic Exit from Infrastructure and Handsets

    Qualcomm sells its network infrastructure division to Ericsson and its handset manufacturing business to Kyocera, focusing the company entirely on chip design and patent licensing a strategic concentration that defines its business model to the present day.

13. 2007Qualcomm

    Snapdragon Platform Introduction

    Qualcomm introduces the Snapdragon brand for its mobile system-on-chip processors, establishing a consumer-facing identity for its mobile silicon that would become synonymous with premium Android smartphone performance over the following decade.

14. 2008Roche

    Severin Schwan becomes CEO

    Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.

15. 2009Roche

    Full Acquisition of Genentech for $46.8 Billion

    Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.

16. 2018Roche

    Foundation Medicine & Flatiron Health Acquisitions

    Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.

17. 2019Qualcomm

    Apple Settlement and Licensing Agreement

    Following years of contentious litigation, Qualcomm and Apple reach a global settlement in April 2019 covering all pending litigation worldwide, with Apple agreeing to a multi-year chip supply deal and a licensing arrangement reportedly involving back payments…

18. 2021Qualcomm

    Nuvia Acquisition

    Qualcomm acquires Nuvia, a CPU startup founded by former Apple Silicon architects, for approximately $1.4 billion, bringing custom CPU design capabilities in-house that power the Oryon cores in Snapdragon 8 Elite and Snapdragon X Elite PC chips.

19. 2023Qualcomm

    Snapdragon X Elite PC Platform Launch

    Qualcomm launches the Snapdragon X Elite and Snapdragon X Plus platforms for Windows PCs, powering Microsoft's Copilot+ PC initiative and marking the company's most significant push into personal computing since the failed Snapdragon 835 PC effort in 2017.

20. 2023Roche

    Acquired Telavant

    F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.

21. 2024Qualcomm

    Snapdragon 8 Elite Launch

    Qualcomm launches the Snapdragon 8 Elite, its first phone chip with custom Oryon CPU cores, built on TSMC's 3nm process.

22. 2025Qualcomm

    Alphawave Semi Acquisition Completed

    Qualcomm completes its roughly $2.4B purchase of Alphawave Semi to accelerate data center connectivity products.

23. 2025Roche

    Group Sales Reach CHF 61.5 Billion

    Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.

24. 2026Qualcomm

    Q2 FY2026 Results and $20B Buyback Authorization

    Qualcomm reports Q2 FY2026 revenue of $10.599B, record quarterly QCT automotive revenue, 20% year-over-year growth in combined QCT automotive and IoT revenue, and a new $20B repurchase authorization.

25. 2026Qualcomm

    Q3 FY2026 Results and $40B Non-Handset Target

    Qualcomm reports Q3 FY2026 revenue of $9.9B (down 4%), automotive revenue up 61% to $1.6B, and raises its FY2029 non-handset revenue target to $40B.

Acquisitions

Questions about Qualcomm vs Roche